Skandinaviska Enskilda Banken (SEB)
XENT

Skandinaviska Enskilda Banken (SEB)’s Intersect ENT, Inc XENT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,511
Closed -$827K – 1098
2022
Q1 		$827K Buy
+29,511
New +$809K ﹤0.01% 773

Skandinaviska Enskilda Banken (SEB)'s XENT Position: Q2 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 29,511 shares — an estimated $827K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $827K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 29,511 Intersect ENT, Inc shares in Q2 2022, an estimated $827K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Intersect ENT, Inc position peaked at $827K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2022, filed 10 Aug 2022.